Tadaoki Tanibuchi
Chief Research and Development Officer (CRO)
Replay available
Astellas Pharma Inc (OTC: ALPMF) Q1 2025 earnings conference call, held 2025-07-30. Replay captured from the company's public earnings webcast.

Chief Research and Development Officer (CRO)
Chief Financial Officer (CFO)
Chief Commercial and Medical Affairs Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Astellas Pharma Inc..
WEBVTT 00:00:00.031 -- 00:00:05.019 FY2025 First Quarter Financial Results Announcement Meeting organized by ASTEDASH Pharma 00:00:05.019 -- 00:00:09.987 Inc. I have a very busy schedule today. I'm serving as a facilitator today. 00:00:09.987 -- 00:00:14.514 I'm Chief Communications and IR Officer. Ikeda, thank you for your time. 00:00:14.514 -- 00:00:17.559 After our presentation, we will move on to the Q&A session. 00:00:17.559 -- 00:00:22.967 We will present based on the presentation material posted on the website under 00:00:22.967 -- 00:00:27.414 IR Meetings. Including Q&A session, we have simultaneous translation between Japanese 00:00:27.414 -- 00:00:31.626 and English. We cannot guarantee the accuracy of simultaneous translation. 00:00:31.626 -- 00:00:37.217 Thank you for understanding. You can choose the language from the Zoom webinar 00:00:37.217 -- 00:00:42.346 screen menu. If you select the original sound, you can listen to the original 00:00:42.346 -- 00:00:45.372 sound without going through the simultaneous translation. 00:00:45.372 -- 00:00:50.185 This is a disclaimer today. This material, oral presentation by representatives for the 00:00:50.185 -- 00:00:53.830 company and answers and statements by representatives for the company in the current 00:00:53.830 -- 00:00:58.415 session includes forward-looking statements based on assumptions and beliefs in light 00:00:58.415 -- 00:01:03.101 of information currently available to management and subject to significant risks and 00:01:03.101 -- 00:01:07.986 uncertainties. Actual financial results may differ materially depending on a number of 00:01:07.986 -- 00:01:09.986 factors. 00:01:11.711 -- 00:01:16.508 They contain information on former protocols including compliance under development, 00:01:16.508 -- 00...